Innate Pharma S.A. (IPHA)
2.13
0.01 (0.47%)
At close: Mar 03, 2025, 3:59 PM
2.09
-1.88%
After-hours: Mar 03, 2025, 04:00 PM EST
Innate Pharma S.A. Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Net Income | -7.57M | -58.1M | -52.81M | -63.98M | -20.76M | 3.05M | -48.38M | 12.64M | -6.71M | -19.65M | -2.89M | -3.2M | -6.98M | -13.66M | -14.63M | -9.85M | -8.92M | -6.04M | -6.13M |
| Depreciation & Amortization | 5.09M | 45.41M | 4.6M | 56.8M | 16.53M | 7.4M | 4.39M | 3.26M | 2.65M | 2.34M | 880K | 839K | 901K | 1.1M | 1.02M | 539K | 536K | 298K | 301K |
| Stock-Based Compensation | 4.26M | 4.25M | 2.62M | 2.48M | 3.83M | 2.71M | 9.83M | 1.03M | 1.01M | 377K | 325K | n/a | 219K | 35K | 1.77M | 1.34M | 1.26M | 1.19M | 214K |
| Other Working Capital | -28.2M | -636K | -6.06M | -45.14M | 38.86M | -47.1M | -16.98M | -58.68M | 202.26M | -883K | -4.27M | -7.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | -2.24M | 1.8M | -1.29M | -544K | -774K | 253K | -88K | -383K | 47K | 170K | 144K | 444K | -274K | -1K | -1.95M | 857K | 111K | 1K | -1.64M |
| Deferred Income Tax | n/a | n/a | -1.68M | 2.65M | -4.14M | 1.16M | 3.17M | -2.61M | -586K | -78K | -9K | n/a | n/a | -259K | 1.06M | n/a | n/a | 49K | 1.64M |
| Change in Working Capital | -32.09M | -12.5M | -9.88M | -49.2M | 40.25M | -47.1M | -16.98M | -50.79M | 211.49M | -1.3M | -9.41M | -8.56M | 19.12M | -666K | 6.78M | -7.63M | -2.27M | 4.87M | -1.64M |
| Operating Cash Flow | -32.56M | -19.15M | -58.46M | -51.81M | 34.92M | -32.53M | -48.06M | -36.85M | 207.91M | -18.13M | -10.97M | -10.47M | 12.99M | -13.45M | -5.94M | -14.74M | -9.28M | 360K | -7.25M |
| Capital Expenditures | -2.35M | -1.12M | -1.33M | -11.28M | -65.4M | -1.43M | -6.03M | -9.39M | -7.4M | -2.34M | -433K | -1.23M | -322K | -408K | -511K | -1.9M | -1.3M | -752K | -112K |
| Acquisitions | n/a | n/a | 7K | 9K | n/a | 22K | 3.06M | 8.04M | n/a | -60K | -120K | n/a | n/a | n/a | n/a | 375K | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | -3M | n/a | n/a | -43.27M | -18.15M | -121.87M | -1.96M | -3M | -2.03M | n/a | n/a | -549K | -15.91M | n/a | -99.45M | -5.36M |
| Sales Maturities Of Investments | 22.77M | 3M | n/a | -9K | 2M | 25.66M | 19.84M | 88.06M | 6.97M | 541K | 2.48M | n/a | 2.77M | n/a | 20M | 41.46M | 5.97M | 61.21M | 4.04M |
| Other Investing Acitivies | -1.79M | -1K | 406K | 912K | 1.28M | 46K | -3.06M | -8.04M | 972K | 2K | 115K | -154K | n/a | 119K | n/a | -1.5M | 304K | n/a | n/a |
| Investing Cash Flow | 20.63M | 1.88M | -917K | -13.37M | -62.12M | 24.28M | -29.46M | 60.51M | -122.3M | -3.82M | -958K | -3.41M | 2.44M | -289K | 18.94M | 22.52M | 4.97M | -38.99M | -1.43M |
| Debt Repayment | -2.36M | -2.03M | 26.63M | -885K | 11.92M | -1.34M | 537K | -685K | -452K | -613K | 314K | -2.26M | -719K | -789K | -257K | 623K | 339K | 712K | 249K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -70K | n/a | n/a | n/a | -112K | -300K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -850K | n/a | n/a | n/a | n/a | -1.2M | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 395K | n/a | 188K | -251K | -159K | 8K | 378K | 69K | 3.36M | 1.7M | 278K | n/a | 36K | n/a | 1.2M | n/a | -1K | 1K | n/a |
| Financial Cash Flow | -1.97M | -1.83M | 26.82M | -1.14M | 77.77M | 61.22M | 915K | -602K | 3.03M | 47.95M | 19.68M | -2.15M | -659K | -893K | 22.56M | 623K | 631K | 42.21M | 249K |
| Net Cash Flow | -13.62M | -19.53M | -33.04M | -66.09M | 50.57M | 52.95M | -76.54M | 23.04M | 88.58M | 25.93M | 7.78M | -16.02M | 14.79M | -14.63M | 35.56M | 8.4M | -3.68M | 3.57M | -8.43M |
| Free Cash Flow | -34.91M | -20.28M | -59.79M | -63.09M | -30.48M | -33.96M | -54.09M | -46.24M | 200.51M | -20.48M | -11.4M | -11.7M | 12.66M | -13.86M | -6.45M | -16.64M | -10.58M | -392K | -7.36M |